catechin has been researched along with Carcinoma, Non-Small Cell Lung in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 22 (70.97) | 24.3611 |
| 2020's | 6 (19.35) | 2.80 |
| Authors | Studies |
|---|---|
| Armeni, T; Cianfruglia, L; Galeazzi, R; Laudadio, E; Minnelli, C; Mobbili, G | 1 |
| Dai, W; Efferth, T; Guo, L; Shan, L; Xiao, X; Yan, B; Yuan, Q; Zhang, J; Zhou, L | 1 |
| Sheng, J; Sun, XL; Wang, LX; Wang, XJ; Wu, YL; Xiang, ZM; Xie, YR; Zhang, DY; Zhang, N; Zi, CT | 1 |
| Chen, A; Chen, L; Feng, Q; Jiang, P; Wu, X; Xu, C; Zeb, F | 1 |
| Galeazzi, R; Laudadio, E; Minnelli, C; Mobbili, G | 1 |
| Chandra, S; Joshi, T; Maiti, P; Nand, M; Ramakrishnan, MA | 1 |
| Chen, A; Feng, Q; Jiang, P; Mariyam, Z; Ul Haq, I; Wu, X; Zhou, M | 1 |
| Cao, J; Chen, G; Jiao, Y; Wu, J; Xing, L; Xue, J; Yang, H; Yu, C; Zhang, Q; Zhang, S; Zhu, W | 1 |
| Honda, Y; Ichihara, E; Kiura, K; Kubo, T; Murakami, T; Ninomiya, T; Ochi, N; Takigawa, N; Tanimoto, M; Yamane, H; Yasugi, M | 1 |
| Chen, P; Gu, JJ; Li, Q; Qiao, KS; Sun, P | 1 |
| Chen, A; Chen, L; Feng, Q; Haq, IU; Jiang, P; Mariyam, Z; Wu, X; Xu, C; Zhou, M | 2 |
| Bhardwaj, V; Mandal, AKA | 1 |
| Chen, G; Jia, L; Li, X; Meng, X; Xing, L; Zhao, H; Zhao, X; Zhu, W | 1 |
| Deng, PB; Hu, CP; Li, YY; Xiong, Z; Yang, HP | 1 |
| Feng, Q; Huang, W; Shi, X; Wang, X; Yang, M; Zhou, DH | 1 |
| Ahn, J; Kim, BM; Lee, JS; Yang, KM; Yoon, JW | 1 |
| Li, H; Sun, X; Xie, P; Xing, L; Yu, J; Zhang, X; Zhao, H; Zhu, W | 1 |
| Feng, Q; Wang, X; Zhou, DH | 1 |
| Lin, B; Liu, F; Liu, X; Shi, J; Tang, X; Zhang, W | 1 |
| Feng, Q; Jiang, P; Li, A; Li, Y; Shen, X; Wang, P; Wang, X; Zhou, J | 1 |
| Arechaga-Ocampo, E; Astudillo-de la Vega, H; Carlos-Reyes, Á; Chávez, JD; Flores-Pérez, A; González-Pérez, A; López-Camarillo, C; Marchat, LA; Ramírez-Torres, N; Romero-Zamora, D; Ruiz-García, E; Sánchez, LL | 1 |
| Gagat, M; Grzanka, A; Hałas, M; Izdebska, M; Klimaszewska-Wiśniewska, A | 1 |
| Feng, Q; Huang, W; Jiang, P; Wang, X; Wu, X | 1 |
| Gao, Z; Gong, M; Hung, MS; Jablon, DM; Lin, YC; Wang, T; Xu, Z; You, L; Zhi, X | 1 |
| Bigelow, RL; Burke, P; Cardelli, JA; Carroll, JL; Coleman, DT; Milligan, SA; Steffan, JJ; Williams, BJ | 1 |
| Echigo, N; Fujiki, H; Kuzuhara, T; Saha, A; Suganuma, M | 1 |
| Go, VL; Jin, YS; Lu, QY; Mao, JT; Nie, WX; Rao, JY; Serio, KJ; Tsu, IH; Zhang, ZF | 1 |
| Hsu, SR; Kao, JY; Liu, LC; Tsai, TC; Tsao, TC; Wang, HC; Way, TD | 1 |
| He, L; Le, AD; Li, X; Shi, J; Tang, X; Zhang, E; Zhang, Q; Zhou, K | 1 |
| Actis-Goretta, L; Keen, CL; Kwik-Uribe, C; Rodriguez, CA; Romanczyk, LJ | 1 |
2 trial(s) available for catechin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy.
Topics: Acute Disease; Aged; Carcinoma, Non-Small-Cell Lung; Catechin; Chemoradiotherapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy Dosage | 2019 |
A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Catechin; Chemoradiotherapy; Cisplatin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage | 2014 |
29 other study(ies) available for catechin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer.
Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Catechin; ErbB Receptors; Humans; Lung Neoplasms; Neoplasm Proteins; Signal Transduction | 2021 |
Green tea-derived theabrownin suppresses human non-small cell lung carcinoma in xenograft model through activation of not only p53 signaling but also MAPK/JNK signaling pathway.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Heterografts; Humans; Lung Neoplasms; MAP Kinase Signaling System; Tea; Tumor Suppressor Protein p53; Zebrafish | 2022 |
Dimeric-(-)-epigallocatechin-3-gallate inhibits the proliferation of lung cancer cells by inhibiting the EGFR signaling pathway.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Lung Neoplasms; Signal Transduction | 2022 |
EGCG regulates CTR1 expression through its pro-oxidative property in non-small-cell lung cancer cells.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cisplatin; Copper Transporter 1; Female; Humans; MAP Kinase Signaling System; Mice; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; RNA, Long Noncoding; Tea; Xenograft Model Antitumor Assays | 2020 |
Conformational Insight on WT- and Mutated-EGFR Receptor Activation and Inhibition by Epigallocatechin-3-Gallate: Over a Rational Basis for the Design of Selective Non-Small-Cell Lung Anticancer Agents.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Membrane; ErbB Receptors; Erlotinib Hydrochloride; Humans; Molecular Docking Simulation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Structure, Secondary | 2020 |
Identification of luteolin -7-glucoside and epicatechin gallate from
Topics: Carcinoma, Non-Small-Cell Lung; Catechin; ErbB Receptors; Glucosides; Humans; Lung Neoplasms; Luteolin; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Kinase Inhibitors; Vernonia | 2021 |
NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Catechin; Cation Transport Proteins; Copper Transporter 1; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplastic Stem Cells; Phenotype; RNA, Long Noncoding; Wnt Signaling Pathway | 2018 |
Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line; Cell Line, Tumor; Female; Heme Oxygenase-1; Humans; Lung Neoplasms; Metformin; Mice; Mice, Inbred BALB C; Mice, Nude; NF-E2-Related Factor 2; Promoter Regions, Genetic; Reactive Oxygen Species; Signal Transduction | 2017 |
Effects of (-)-epigallocatechin-3-gallate on EGFR- or Fusion Gene-driven Lung Cancer Cells.
Topics: Anaplastic Lymphoma Kinase; Animals; Blood Proteins; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Crizotinib; Disease Models, Animal; ErbB Receptors; Female; Gene Rearrangement; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Oncogene Proteins, Fusion; Polyphenols; Protein S; Protein-Tyrosine Kinases; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Tea | 2017 |
Study of EGCG induced apoptosis in lung cancer cells by inhibiting PI3K/Akt signaling pathway.
Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |
Epigallocatechin-3-gallate inhibited cancer stem cell-like properties by targeting hsa-mir-485-5p/RXRα in lung cancer.
Topics: A549 Cells; Analysis of Variance; Animals; Anticarcinogenic Agents; Carcinoma, Non-Small-Cell Lung; Catechin; Down-Regulation; Gene Knockdown Techniques; Gene Silencing; HEK293 Cells; Humans; Lung Neoplasms; Mice; Mice, Nude; MicroRNAs; Molecular Mimicry; Neoplastic Stem Cells; Retinoid X Receptor alpha; Signal Transduction; Transfection; Up-Regulation; Xenograft Model Antitumor Assays | 2018 |
EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Lung Neoplasms; Mice; Mice, Nude; MicroRNAs; Neoplastic Stem Cells; Xenograft Model Antitumor Assays | 2018 |
Next-Generation Sequencing Reveals the Role of Epigallocatechin-3-Gallate in Regulating Putative Novel and Known microRNAs Which Target the MAPK Pathway in Non-Small-Cell Lung Cancer A549 Cells.
Topics: Carcinoma, Non-Small-Cell Lung; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Lung Neoplasms; MAP Kinase Signaling System; MicroRNAs; Nucleic Acid Conformation; Reproducibility of Results; Transcriptome | 2019 |
Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2.
Topics: Angiogenesis Inhibitors; Angiopoietin-1; Angiopoietin-2; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Catechin; Chemotherapy, Adjuvant; Cisplatin; Drug Therapy, Combination; Extracellular Fluid; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Oxygen | 2013 |
Combination of low concentration of (-)-epigallocatechin gallate (EGCG) and curcumin strongly suppresses the growth of non-small cell lung cancer in vitro and in vivo through causing cell cycle arrest.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Clone Cells; Curcumin; Cyclin B1; Cyclin D1; DNA Replication; Female; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude | 2013 |
Catechin-7-O-xyloside induces apoptosis via endoplasmic reticulum stress and mitochondrial dysfunction in human non-small cell lung carcinoma H1299 cells.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 6; Catechin; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Transplantation; Poly(ADP-ribose) Polymerases; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transcription Factor CHOP; Xylose | 2014 |
EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cisplatin; Computational Biology; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Transfection; Up-Regulation | 2014 |
Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Nicotine; Smoking; Tea; Xenograft Model Antitumor Assays | 2015 |
EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; Female; Heat-Shock Proteins; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Membrane Transport Proteins; Mice, Inbred BALB C; Mice, Nude; Proteolysis; Xenograft Model Antitumor Assays | 2015 |
Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Proteomics; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
Green tea extract induces protective autophagy in A549 non-small lung cancer cell line.
Topics: Antioxidants; Autophagy; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line; Humans; Lung Neoplasms; Plant Extracts; Polyphenols; Tea | 2015 |
NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells.
Topics: A549 Cells; Animals; Anticarcinogenic Agents; Carcinoma, Non-Small-Cell Lung; Catechin; Cation Transport Proteins; Cell Proliferation; Chemotherapy, Adjuvant; Cisplatin; Copper Transporter 1; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Mice; Mice, Nude; MicroRNAs; Microscopy, Fluorescence; RNA Interference; RNA, Long Noncoding; RNA, Small Interfering; Up-Regulation; Xenograft Model Antitumor Assays | 2016 |
Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Anticarcinogenic Agents; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Luciferases; Lung Neoplasms; Promoter Regions, Genetic; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator | 2009 |
The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Erlotinib Hydrochloride; Humans; Indoles; Lung Neoplasms; Male; Mice; Mice, SCID; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Quinazolines; Sulfonamides; Xenograft Model Antitumor Assays | 2009 |
New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Cycle Proteins; Cell Growth Processes; Cell Line, Tumor; Curcumin; Down-Regulation; Drug Evaluation, Preclinical; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Nuclear Proteins; Protein Kinase Inhibitors; RNA, Small Interfering; Transcription Factor CHOP | 2010 |
White tea extract induces apoptosis in non-small cell lung cancer cells: the role of peroxisome proliferator-activated receptor-{gamma} and 15-lipoxygenases.
Topics: Anilides; Apoptosis; Arachidonate 15-Lipoxygenase; Carcinoma, Non-Small-Cell Lung; Catechin; Drug Evaluation, Preclinical; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Hydroxyeicosatetraenoic Acids; Lung Neoplasms; Plant Extracts; PPAR gamma; Tea; Tumor Cells, Cultured | 2010 |
EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; MAP Kinase Signaling System; Plant Extracts; Smad2 Protein; Transforming Growth Factor beta | 2012 |
(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression; Human papillomavirus 16; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oncogene Proteins; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Repressor Proteins; Signal Transduction; Transfection; Vascular Endothelial Growth Factor A | 2013 |
Cytotoxic effects of digalloyl dimer procyanidins in human cancer cell lines.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Survival; Central Nervous System Neoplasms; Depsides; Female; Flavonoids; Gallic Acid; Gastrointestinal Neoplasms; Humans; Male; Melanoma; Proanthocyanidins; Prostatic Neoplasms | 2008 |